跳至主要内容
临床试验/NCT05266859
NCT05266859已完成2 期

Comparison of Efficacy of Platelet-rich Fibrin, Mineral Trioxide Aggregate and Calcium Hydroxide as Pulpotomy Medicaments in Permanent Teeth With Irreversible Pulpitis

Liaquat College of Medicine and Dentostry1 个研究点 分布在 1 个国家目标入组 114 人开始时间: 2019年8月28日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
114
试验地点
1
主要终点
Clinical Success or Failure

研究概览

简要总结

Of all the various pulpotomy medicaments that have been studied till to date, three agents have been selected for this study to compare their efficacy. CH being the control, MTA being one of the most recommended biomaterial and PRF that in addition to being a biomaterial is an autologous agent. Uptil now there have been no prospective trials using these three pulpotomy agents in mature permanent teeth with irreversible pulpitis in our part of the world and even the international studies that have been done utilized different methodologies with no unanimous conclusion. This is the reason that at present this treatment regime (pulpotomy) showing better perspectives cannot be presented with confidence as a predictable treatment option to the patients with irreversible pulpitis. By virtue of this study this challenge is being undertaken.

Hypothesis:

ALTERNATE HYPOTHESIS There is a difference between the efficacy of the PRF, MTA and CH when used as pulpotomy medicaments in mature permanent teeth with irreversible pulpitis NULL HPOTHESIS There is no difference in efficacy of the PRF, MTA and CH when used as pulpotomy medicaments in mature permanent teeth with irreversible pulpitis

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
10 Years 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Patients with permanent teeth with completely formed roots diagnosed with irreversible pulpitis i.e. showing signs and symptoms as spontaneous, lingering pain initiated by hot and cold stimulus and /or radiating. Pulp being exposed or near to exposure by caries or alternatively by trauma.

排除标准

  • •CLINICALLY Teeth with
  • •Necrotic pulp
  • •History of swelling, abscess , fistula and/ or sinus tract
  • •Doubtful restorability as indicated by over all Dental Practicality Index- (DPI) > 2 (Dawood and Patel 2017) will be excluded
  • •Periodontal disease
  • •Uncontrolled bleeding (more that 10 mins.) of pulp after removal of inflamed part.
  • •No bleeding of pulp at all after access into pulp RADIOGRAPHICALLY (with the use of periapical radiographs) Teeth with
  • •Internal/ external pathologic root resorption
  • •Pulp canal obliteration
  • •Periapical / furcal radiolucency
  • •Resorbed roots.
  • •Crestal bone loss Generally patients
  • •With systemic diseases, bleeding disorders, physical or mental disability, pregnant or nursing.
  • •On opioid or steroid therapy or anticoagulants and/or on any kind of antibiotics.
  • •Who have gone through some previous treatment for the same tooth other than filling.

研究组 & 干预措施

Group III- PRF (Experimental)

Experimental

Group III will receive PRF. PRF is platelet-rich fibrin that is a biocompatible product derived from patient's own blood. It is formed by centrifugation of the blood of the patient. It provides the growth factors and promotes regeneration of the pulp

干预措施: PRF (Other)

Group II- MTA (Experimental)

Experimental

Group II will receive MTA (Mineral Trioxide Aggregate). MTA is a calcium silicate based highly biocompatible material that is commonly used for pulpotomies in deciduous teeth along with the regenerative procedures in permanent and deciduous teeth

干预措施: MTA (Other)

Group I- Calcium hydroxide (Control)

Active Comparator

Group I will receive Calcium hydroxide . Calcium hydroxide is a gold standard medicament for the pulpotomy in deciduous teeth. It has antibacterial effects and widely used to disinfect the root canals.

This group will act as a control

干预措施: Calcium hydroxide (Other)

结局指标

主要结局

Clinical Success or Failure

时间窗: 12 months

Incidence of pain, swelling, sinus tract formation, tenderness to percussion after specified time period after intervention

Radiographic Success or Failure

时间窗: 12 months

Incidence of Periapical radiolucency or widening and Resorption

次要结局

未报告次要终点

研究者

发起方
Liaquat College of Medicine and Dentostry
申办方类型
Other
责任方
Principal Investigator
主要研究者

Naheed Najmi

Vice Principal and Registrar

Liaquat College of Medicine and Dentostry

研究点 (1)

Loading locations...

相似试验